VERICEL CORPORATION - COMMON STOCK

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

15 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

07 Aug 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel Reports Second Quarter 2024 Financial Results

01 Aug 2024 07:55:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: VERICEL CORPORATION - COMMON STOCK

25 Jul 2024 11:21:53 By NetDania Notify

NetDania - New 12 months High: VERICEL CORPORATION - COMMON STOCK

24 Jul 2024 10:17:47 By NetDania Notify

NetDania - New 12 months High: VERICEL CORPORATION - COMMON STOCK

23 Jul 2024 11:50:39 By NetDania Notify

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

22 Jul 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

18 Jul 2024 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: VERICEL CORPORATION - COMMON STOCK

17 Jul 2024 10:10:09 By NetDania Notify

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

11 Jun 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

22 May 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

08 May 2024 07:55:00 By Nasdaq GlobeNewswire

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

24 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

29 Feb 2024 07:55:00 By Nasdaq GlobeNewswire

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

27 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

15 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

05 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

09 Jan 2024 07:55:00 By Nasdaq GlobeNewswire

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

03 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

08 Nov 2023 07:55:00 By Nasdaq GlobeNewswire